Advisornet Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-259
| Closed | -$1.97K | – | 1973 |
|
|
2024
Q3 | $1.97K | Hold |
259
| – | – | ﹤0.01% | 1747 |
|
|
2024
Q2 | $1.6K | Hold |
259
| – | – | ﹤0.01% | 1665 |
|
|
2024
Q1 | $1.32K | Sell |
259
-17
| -6% | -$86 | ﹤0.01% | 1694 |
|
|
2023
Q4 | $1.65K | Buy |
276
+9
| +3% | +$54 | ﹤0.01% | 1764 |
|
|
2023
Q3 | $1.89K | Sell |
267
-11
| -4% | -$78 | ﹤0.01% | 1651 |
|
|
2023
Q2 | $1.96K | Sell |
278
-2
| -0.7% | -$14 | ﹤0.01% | 1724 |
|
|
2023
Q1 | $2.34K | Buy |
280
+14
| +5% | +$117 | ﹤0.01% | 1664 |
|
|
2022
Q4 | $3.05K | Buy |
266
+7
| +3% | +$80 | ﹤0.01% | 1576 |
|
|
2022
Q3 | $3K | Hold |
259
| – | – | ﹤0.01% | 1571 |
|
|
2022
Q2 | $3K | Sell |
259
-1,500
| -85% | -$17.4K | ﹤0.01% | 1586 |
|
|
2022
Q1 | $29K | Hold |
1,759
| – | – | ﹤0.01% | 1123 |
|
|
2021
Q4 | $24K | Hold |
1,759
| – | – | ﹤0.01% | 1232 |
|
|
2021
Q3 | $25K | Hold |
1,759
| – | – | ﹤0.01% | 1183 |
|
|
2021
Q2 | $28K | Hold |
1,759
| – | – | ﹤0.01% | 1130 |
|
|
2021
Q1 | $18K | Buy |
1,759
+259
| +17% | +$2.65K | ﹤0.01% | 1201 |
|
|
2020
Q4 | $11K | Buy |
+1,500
| New | +$11K | ﹤0.01% | 1245 |
|
|
2019
Q4 | – | Sell |
-500
| Closed | -$1K | – | 1845 |
|
|
2019
Q3 | $1K | Buy |
+500
| New | +$1K | ﹤0.01% | 1718 |
|